ID: ALA4473744

Max Phase: Preclinical

Molecular Formula: C15H17N3O4

Molecular Weight: 303.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)C(=O)NCc1ccc(-c2cncc(C(=O)O)c2N)o1

Standard InChI:  InChI=1S/C15H17N3O4/c1-8(2)14(19)18-5-9-3-4-12(22-9)10-6-17-7-11(13(10)16)15(20)21/h3-4,6-8H,5H2,1-2H3,(H2,16,17)(H,18,19)(H,20,21)

Standard InChI Key:  AZJNAMDMMVLNLP-UHFFFAOYSA-N

Associated Targets(Human)

T1R2/T1R3 282 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.32Molecular Weight (Monoisotopic): 303.1219AlogP: 1.89#Rotatable Bonds: 5
Polar Surface Area: 118.45Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.72CX Basic pKa: 8.20CX LogP: -0.16CX LogD: -0.17
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.78Np Likeness Score: -0.87

References

1. Yamada K, Nakazawa M, Matsumoto K, Tagami U, Hirokawa T, Homma K, Mori S, Matsumoto R, Saikawa W, Kitajima S..  (2019)  Unnatural Tripeptides as Potent Positive Allosteric Modulators of T1R2/T1R3.,  10  (5): [PMID:31098002] [10.1021/acsmedchemlett.9b00051]

Source